LAWREN WU,JOSEPH R. ARRON,MICHAEL DILLON,DAVID F. CHOY,SUE SOHN,CHRISTOPH SPIESS,WHITNEY SHATZ
申请号：
US15441059
公开号：
US20170334985A1
申请日:
2017.02.23
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention provides anti-IL-13/IL-17 bispecific antibodies, in particular, anti-IL13/IL17 AA, AF and FF antibodies and methods of using the same, including without limitation, methods of using the anti-IL-13/IL-17 bispecific antibodies for treating moderate to severe asthma and/or eosinophilic asthma.
